NO20032148D0 - Nye anvendelser av kombinerte 5-HT1A-agonister og serotoningjenopptaksinhibitorer - Google Patents

Nye anvendelser av kombinerte 5-HT1A-agonister og serotoningjenopptaksinhibitorer

Info

Publication number
NO20032148D0
NO20032148D0 NO20032148A NO20032148A NO20032148D0 NO 20032148 D0 NO20032148 D0 NO 20032148D0 NO 20032148 A NO20032148 A NO 20032148A NO 20032148 A NO20032148 A NO 20032148A NO 20032148 D0 NO20032148 D0 NO 20032148D0
Authority
NO
Norway
Prior art keywords
combined
serotonin reuptake
reuptake inhibitors
new applications
ht1a agonists
Prior art date
Application number
NO20032148A
Other languages
English (en)
Other versions
NO20032148L (no
Inventor
Gerd Bartoszyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20032148L publication Critical patent/NO20032148L/no
Publication of NO20032148D0 publication Critical patent/NO20032148D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20032148A 2000-11-14 2003-05-13 Nye anvendelser av kombinerte 5-HT1A-agonister og serotoningjenopptaksinhibitorer NO20032148D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00124815 2000-11-14
PCT/EP2001/011952 WO2002040024A1 (en) 2000-11-14 2001-10-16 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors

Publications (2)

Publication Number Publication Date
NO20032148L NO20032148L (no) 2003-05-13
NO20032148D0 true NO20032148D0 (no) 2003-05-13

Family

ID=8170369

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032148A NO20032148D0 (no) 2000-11-14 2003-05-13 Nye anvendelser av kombinerte 5-HT1A-agonister og serotoningjenopptaksinhibitorer

Country Status (22)

Country Link
US (1) US20040082594A1 (no)
EP (1) EP1333832B1 (no)
JP (1) JP2004513924A (no)
KR (1) KR20030059244A (no)
CN (1) CN1222291C (no)
AR (1) AR031335A1 (no)
AU (2) AU2002215027B2 (no)
BR (1) BR0115296A (no)
CA (1) CA2428511C (no)
CZ (1) CZ302484B6 (no)
DE (1) DE60131675T2 (no)
ES (1) ES2296820T3 (no)
HK (1) HK1060697A1 (no)
HU (1) HUP0302751A3 (no)
MX (1) MXPA03004166A (no)
NO (1) NO20032148D0 (no)
PL (1) PL204331B1 (no)
RU (1) RU2288719C2 (no)
SK (1) SK287337B6 (no)
UA (1) UA79583C2 (no)
WO (1) WO2002040024A1 (no)
ZA (1) ZA200304606B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10305739A1 (de) 2003-02-11 2004-08-19 Merck Patent Gmbh Benzofuranderivate
DE602004014190D1 (de) 2003-12-23 2008-07-10 Lundbeck As Valby H 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri
US7893261B2 (en) 2004-03-26 2011-02-22 Baylor University Serotonin reuptake inhibitors
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
WO2006034788A1 (en) * 2004-09-28 2006-04-06 Merck Patent Gmbh Combinations of n-(indolecarbonyl-)piperazine derivatives and serotonin reuptake inhibitors
AR054393A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
RU2462462C2 (ru) * 2006-08-11 2012-09-27 ДСМ АйПи АССЕТС Б.В. Производные лигустилида для лечения расстройств центральной нервной системы

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
DE19512639A1 (de) * 1995-04-05 1996-10-10 Merck Patent Gmbh Benzonitrile und -fluoride
DE19637237A1 (de) * 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate
DE19730989A1 (de) * 1997-07-18 1999-01-21 Merck Patent Gmbh Piperazin-Derivate
SK492001A3 (en) * 1998-07-20 2001-08-06 Merck Patent Gmbh Biphenyl derivatives

Also Published As

Publication number Publication date
AU2002215027B2 (en) 2006-10-05
PL360310A1 (en) 2004-09-06
CN1222291C (zh) 2005-10-12
HUP0302751A3 (en) 2007-06-28
CN1474691A (zh) 2004-02-11
SK6382003A3 (en) 2003-11-04
RU2288719C2 (ru) 2006-12-10
AR031335A1 (es) 2003-09-17
DE60131675D1 (de) 2008-01-10
EP1333832A1 (en) 2003-08-13
NO20032148L (no) 2003-05-13
SK287337B6 (sk) 2010-07-07
MXPA03004166A (es) 2003-09-22
KR20030059244A (ko) 2003-07-07
JP2004513924A (ja) 2004-05-13
CZ302484B6 (cs) 2011-06-08
US20040082594A1 (en) 2004-04-29
UA79583C2 (en) 2007-07-10
ES2296820T3 (es) 2008-05-01
ZA200304606B (en) 2004-09-13
CA2428511A1 (en) 2002-05-23
CZ20031433A3 (cs) 2003-09-17
HK1060697A1 (en) 2004-08-20
BR0115296A (pt) 2003-09-02
AU1502702A (en) 2002-05-27
DE60131675T2 (de) 2008-11-20
WO2002040024A1 (en) 2002-05-23
EP1333832B1 (en) 2007-11-28
HUP0302751A2 (hu) 2003-11-28
PL204331B1 (pl) 2010-01-29
CA2428511C (en) 2009-12-29

Similar Documents

Publication Publication Date Title
NO20032465D0 (no) Nye mandelsyre-derivater og anvendelse derav som trombininhibitorer
NO20031744D0 (no) Nye ikke-imadazolforbindelser og farmasöytisk preparat omfattende slike
IS2529B (is) Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar
NO20044194L (no) Nye inhibitorer av histon-deacetylase
NO20044314L (no) Sulfonyldenvater som nye inhibitorer av histon-deacetylase
IS8806A (is) Fenýl-píperidín afleiður sem serótónín endurupptökuhindrar
DK1638933T3 (da) N-pyrrolidin-3-yl-amid-derivater som serotonin- og noradrenalin-genoptagelses inhibitorer
NO20005265D0 (no) Substituerte benzamider, deres fremstilling og anvendelse som inhibitorer av cystin-proteaser
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
NO20041272L (no) Tetracycline derivatives and methods of use thereof
DK1170288T3 (da) Diphenylurinstofderivater og deres anvendelse som alfa2/5-HT2c-antagonister
NO20032148L (no) Nye anvendelser av kombinerte 5-HT1A-agonister og serotoningjenopptaksinhibitorer
NO20052124D0 (no) Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse
ATE499096T1 (de) Kombination von serotonin-wiederaufnahme-hemmern und agomelatin
NO20023662L (no) Nye heterocykliske derivater, fremgangsmåte ved fremstilling og farmasöytiske sammensetninger inneholdende det samme
DK1786759T3 (da) Nye derivater af 3,5-seco-4-nor-cholestan og deres anvendelser
NO20023956D0 (no) Priperidin- og piperazinsubstituerte N-hydroksyformamider som inhibitorer av metalloproteinaser
NO20032248D0 (no) Ny anvendelse av kombinerte 5-HT1A-agonister og selektive inhibitorer for serotoningjenopptaksinhibitorer
NO20035332D0 (no) Nye heterocykliske derivater og medisinsk anvendelse derav
NO20030822D0 (no) Nye forbindelser og fremgangsmåter
DK1002794T3 (da) 4-(aryl)(aryloxy)methylpiperidinderivater og anvendelse deraf som serotonin og/eller noradrenalingenoptagelsesinhibitorer
NO20025509D0 (no) Ny polymorf av torasemid
NO20035331D0 (no) Nye heterocyklisk forbindelse og medisinsk anvendelse derav
NO20010685L (no) Nye farmasøytiske anvendelser av NOS-inhibitorer
NO20035647L (no) Ny anvendelse av cyclolignaner og nye cycloliganer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application